Clinical trial
Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by…
NCT00365170 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00365170 |
|---|---|
| Title | Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes |
| Official title | A Randomised, Parallel-group, Open-label, Multinational Trial Comparing the Safety and Efficacy of Insulin Aspart (NovoRapid®) Versus Human Insulin (Actrapid®), Used in a Multiple Injection Regimen, in the Treatment of Pregnant Women With Type 1 Diabetes, Focusing on Maternal Hypoglycaemia and… |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes, Diabetes Mellitus, Type 1 |
| Intervention type | Drug |
| Interventions | human insulin, insulin aspart |
| Enrollment | 419 |
| Start date | Sep 1, 2002 |
| Primary completion | Apr 1, 2005 |
| Completion | Apr 1, 2005 |
| First posted | Aug 17, 2006 |
| Last update posted | Dec 21, 2016 |
| Countries | Argentina, Austria, Bulgaria, Canada, Croatia, Denmark, Finland, France, Germany, Greece, Ireland, Israel and 6 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: